Esophageal ulceration due to alendronate

Endoscopy

Volumn 28, Issue 6, 1996, Pages 529-

  Sorrentino, D ^a,b   Trevisi, A ^a   Bernardis, V ^a   Debiase, F ^a   Labombarda, A ^a   Bartoli, E ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; OMEPRAZOLE; SUCRALFATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ESOPHAGUS ULCER; GASTROINTESTINAL ENDOSCOPY; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; TIME; ULCER HEALING;

EID: 9544254006     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1005544     Document Type: Article

References (3)

1. Fleisch H. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Rec Res Cancer Res 1989; 116: 1-28.
2. Adami S, Mian M, Gatti P, et al. Effect of two oral doses of alendronate in the treatment of Paget's disease of bone. Bone 1994; 15: 415-7.
3. Fleisch H. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. In: Baker G, ed. Handbook of experimental pharmacology. Berlin: Springer, 1988: 441-66.